Understanding Your AML Genetic Profile: The Key to Personalised Treatment
Receiving an Acute Myeloid Leukaemia diagnosis can be overwhelming, but knowledge is your greatest ally. Our AML Prognostic Panel provides the genetic insights your medical team needs to create a treatment plan specifically tailored to your unique cancer profile. This isn’t just another test – it’s a roadmap to more effective, targeted therapy.
What This Test Reveals About Your Leukaemia
This comprehensive genetic analysis examines the specific mutations driving your AML, including:
- FLT3 mutations – Help determine if targeted therapy drugs may be effective
- NPM1 and CEBPA mutations – Indicate potentially more favourable prognosis
- Chromosomal abnormalities (AML/ETO, INV[16], PML/RARA) – Guide treatment intensity decisions
Think of this as your cancer’s genetic fingerprint – understanding these details helps your doctors choose treatments that work specifically against your type of leukaemia.
Who Should Consider This Genetic Testing?
This test is essential for:
- Newly diagnosed AML patients – Before starting treatment to guide therapy choices
- Patients experiencing treatment resistance – To identify why current treatments aren’t working
- Those considering clinical trials – Many trials require specific genetic profiles
- Patients seeking second opinions – Confirm diagnosis and treatment recommendations
If you’re facing AML treatment decisions, this genetic information could significantly impact your treatment success and quality of life.
Why Genetic Testing Matters for Your Treatment Journey
Knowing your genetic profile provides:
- Personalised treatment plans – Avoid one-size-fits-all approaches
- Better prediction of treatment response – Understand how your cancer may react to different therapies
- Reduced unnecessary side effects – Target treatments to what’s most likely to work
- Peace of mind – Make decisions based on scientific evidence, not guesswork
- Potential cost savings – Avoid expensive treatments that may not be effective for your specific mutation profile
Understanding Your Results: Clear Guidance Every Step
We know genetic reports can be confusing. That’s why our results include:
- Plain language explanations of what each mutation means
- Treatment implications – How results affect your therapy options
- Prognostic information – What your genetic profile suggests about disease course
- Discussion points for your doctor – Questions to ask about your results
Your results will be ready within 5-7 days, giving you and your medical team the information needed to move forward with confidence.
Transparent Pricing – Investing in Your Treatment Success
| Service | Regular Price | Special Price | Savings |
|---|---|---|---|
| AML Prognostic Panel (Full Genetic Analysis) | ZAR 7,000 | ZAR 2,350 |
This comprehensive testing could save you thousands in ineffective treatments and provide priceless peace of mind about your treatment direction.
Why South Africans Trust Oracle Genomics
- Nationwide Coverage – Accessible testing centres in Johannesburg, Cape Town, Durban, Pretoria and nationwide
- Expert Analysis – Our haematology specialists have years of experience in genetic cancer testing
- Rapid Turnaround – 5-7 day results mean faster treatment decisions
- Medical Grade Accuracy – Cell culture + End point PCR methodology ensures reliable results
- Patient-Focused Approach – We understand the emotional journey of cancer diagnosis
Take Control of Your Treatment Journey Today
Don’t leave your treatment to chance. Understanding your genetic profile is the first step toward more effective, personalised care. With our special pricing of ZAR 7,000, this crucial information is more accessible than ever.
Note: This test requires a doctor’s prescription (except for surgery, pregnancy, or travel abroad cases). Our team can help connect you with appropriate medical professionals if needed.
Your genetic profile holds the key to better treatment outcomes. Take the first step toward personalised care today.
